Sign in

CIK 0001857044 · Non-accelerated filer<br>Smaller reporting company

Indaptus Therapeutics, Inc.

Sign in to watch
Ticker
INDP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
863158720
Phone
(646) 427-2727
Business address
3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK, NY, 10019
Former names
Intec Parent Inc.
  1. POS AM Other Post-effective Amendment for Registration Statement
  2. POS AM Other Post-effective Amendment for Registration Statement
  3. 8-K Event Results of operations
  4. 10-K Report Annual Report
  5. 4 Derivatives Options or other derivatives
  6. SC 13G/A Stake Amended Statement of Ownership
  7. 4 Derivatives Options or other derivatives
  8. 3 Insider Initial Statement of Ownership
  9. 4 Open-market sale CSO and Director sold 20,000 shares at an average $5.00 ($100,043)
  10. 8-K Event Executive or director change
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 8-K Event Executive or director change · Regulation FD disclosure
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 8-K Event Executive or director change
  18. EFFECT Other Notice of Effectiveness
  19. POS AM Other Post-effective Amendment for Registration Statement
  20. 4 Open-market buy CEO and Director bought 11,187 shares at $5.82 ($65,108)

Page 14 of 18 · 343 filings